John R. Moore, General Counsel at Edgewise Therapeutics, Inc. (EWTX), sold 39,872 shares at $6.63 ($259K) on 2022-06-08, disclosed to the SEC on 2022-06-10.
Open-market sale of $259k EWTX by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.63 | 12,566 | $83K | 32.1% |
| 2 | $6.63 | 12,566 | $83K | 32.1% |
| 3 | $6.49 | 7,615 | $49K | 19.1% |
| 4 | $6.05 | 7,125 | $43K | 16.6% |
| Total | $6.50 avg | 39,872 | $259K | 100% |
| Filing → |
| EWTX | SELL | 2025-05-07 | $32K | — | Filing → |
| EWTX | SELL | 2024-09-24 | $2.6M | — | Filing → |
| EWTX | SELL | 2024-05-03 | $37K | — | Filing → |